SCHEMBL25015964

SCHEMBL25015964

CN1CCN(C(=O)c2cc3ccc(C(=N)NC(=O)OC(C)(C)C)cc3n2Cc2cccc3ccccc23)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 4/20 0.39
▸ TSHR P16473 3/20 0.38
▸ HPGD P15428 1/20 0.38
▸ ACHE P22303 1/20 0.38
▸ CYP2C9 P11712 3/20 0.38
▸ CYP2C19 P33261 3/20 0.38
▸ CYP1A2 P05177 2/20 0.38
▸ CYP3A4 P08684 2/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ RHEB Q15382 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ HTR1A P08908 2/20 0.36
▸ HTR1D P28221 2/20 0.36
▸ HTR1B P28222 2/20 0.36
▸ CTSS P25774 1/20 0.36
▸ CTSK P43235 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.35
▸ F10 P00742 1/20 0.35
▸ BCL2 P10415 1/20 0.35
▸ MCL1 Q07820 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25017943 0.92 ACHE (0.43) CNR2TSHRACHECYP2C9CYP2C19
SCHEMBL25016101 0.89 HTR2C (0.44) CNR2TSHRACHECYP2C9CYP2C19
SCHEMBL25015970 0.88 CYP3A4 (0.38) CNR2TSHRACHECYP2C9CYP2C19
SCHEMBL25015739 0.88 CYP3A4 (0.38) CNR2TSHRACHECYP2C9CYP2C19
SCHEMBL21822737 0.87 CTSS (0.42) RHEBCTSSCTSKF10MCL1
SCHEMBL31689662 0.87 CTSS (0.42) RHEBCTSSCTSKF10MCL1
SCHEMBL25016295 0.86 USP30 (0.41) TSHRCYP2C9CYP2C19CYP1A2CYP3A4
SCHEMBL25016100 0.86 USP30 (0.41) TSHRCYP2C9CYP2C19CYP1A2CYP3A4
SCHEMBL28598750 0.85 F10 (0.40) F10KDM4E
SCHEMBL25017069 0.83 F10 (0.47) CNR2TSHRHPGDRHEBF10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230043159-A1 MATRIPTASE 2 INHIBITORS AND USES THEREOF DISC MEDICINE, INC. 2023-02-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230043159-A1 MATRIPTASE 2 INHIBITORS AND USES THEREOF MMP7, MATR3, SPINT2 CNR2 4734/4885TSHR 4421/4885HPGD 1516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback